Brief: Longboard Pharmaceuticals Provides Corporate Update And Reports Second Quarter 2022 Financial Results
04/08/2022 22:43
Aug 4 (Reuters) - Longboard Pharmaceuticals Inc LBPH.O :
* LONGBOARD PHARMACEUTICALS PROVIDES CORPORATE UPDATE
AND REPORTS
SECOND QUARTER 2022 FINANCIAL RESULTS
* NET LOSS WAS $11.4 MILLION, OR $0.67 PER SHARE, FOR THREE
MONTHS
ENDED JUNE 30, 2022
* Q2 EARNINGS PER SHARE VIEW $-0.57 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbqmHBZ
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions